A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer

NC-6004 is a nanoparticle developed using micellar technology that can improve release of cisplatin, a standard treatment for many cancer types, and achieve selective distribution to tumors. Here, in the Phase II portion of this study, the activity, safety, tolerability, and effects on quality of li...

Descripción completa

Detalles Bibliográficos
Autores principales: Volovat, Simona Ruxandra, Ciuleanu, Tudor-Eliade, Koralewski, Piotr, Olson, Juneko E. Grilley, Croitoru, Adina, Koynov, Krassimir, Stabile, Stefano, Cerea, Giulio, Osada, Atsushi, Bobe, Iulian, Volovat, Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443368/
https://www.ncbi.nlm.nih.gov/pubmed/32913555
http://dx.doi.org/10.18632/oncotarget.27684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443368/
https://www.ncbi.nlm.nih.gov/pubmed/32913555
http://dx.doi.org/10.18632/oncotarget.27684

Ejemplares similares